Association of impaired glucose tolerance with increased heart rate and subclinical inflammation

Hellenic Journal of Cardiology

Volumn 46, Issue 6, 2005, Pages 394-401

  Diakakis, George F ^a   Parthenakis, Fragiskos I ^a   Mavrakis, Hercules E ^a   Patrianakos, Alexandros P ^a   Zacharis, Evangelos A ^a   Nyktari, Evangelia G ^a   Ganotakis, Emmanuel S ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Heart rate; Impaired glucose tolerance; Interleukins; Tnf a; Variability

Indexed keywords

CYTOKINE;

ADULT; AGE DISTRIBUTION; AMBULATORY CARE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; FEMALE; HEART RATE VARIABILITY; HUMAN; IMMUNOASSAY; IMPAIRED GLUCOSE TOLERANCE; MALE;

ADULT; AGED; GLUCOSE INTOLERANCE; HEART RATE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONITORING, AMBULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30944439639     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898.
2. Haffner SJ, Cassells H: Hyperglycemia as a cardiovascular risk factor. Am J Med 2003; 115 (suppl 8A): 6S-11S.
3. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990; 131: 443-453.
4. Festa A, D'Agostino R Jr, Mykkanen L, et al: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 1999; 19: 562-568.
5. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
6. Haffner SM: Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 2003; 61 Suppl 1: S9-S18.
7. Ballantyne CM, Nambi V: Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6: 21-29.
8. Fiotti N, Giansante C, Ponte E, et al: Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999; 145: 51-60.
9. Choi KM, Lee J, Lee KW, et al: Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract 2004; 64: 99-106.
10. Bellavere F: Heart rate variability in patients with diabetes and other noncardiological diseases: Heart Rate Variability. Futura Publishing Company Inc., New York 1995; pp 507-516.
11. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al: European Society of Cardiology: Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003; 24: 13-15.
12. American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005; 28 (suppl 1): S37-S42.
13. Falcone C, Nespoli L, Geroldi D, et al: Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. Int J Cardiol 2003; 90: 219-227.
14. Javorka M, Javorkova J, Tonhajzerova I, Calkovska A, Javorka K: Heart rate variability in young patients with diabetes mellitus and healthy subjects explored by Poincare and sequence plots. Clin Physiol Funct Imaging 2005; 25: 119-127.
15. Palatini P, Julius S: Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hyertens 2004; 26: 637-644.
16. Muller S, Martin S, Koenig W, et al: Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002; 45: 805-812.
17. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2004; 102: 42-47.
18. Retter AS, Frishman WH: The role of tumor necrosis factor in cardiac disease. Heart Dis 2001; 3(5): 319-325.
19. Danielsson P, Truedsson L, Eriksson KF, Norgren L: Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med 2005; 10: 191-198.
20. Maestroni GJ, Cosentino M, Marino F, et al: Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis? Exp Hematol 1998; 26: 1172-1177.
21. Juttler E, Tarabin V, Schwaninger M: Interleukin-6 (IL-6): A possible neuromodulator induced by neuronal activity. Neuroscientist 2002; 8: 268-275.
22. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997; 15: 307-339.
23. Maestroni GJ, Conti A: Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol 1994; 22: 313-320.
24. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF: Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middleaged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-370.
25. Winkler G, Lakatos P, Salamon F, et al: Elevated serum TNF-a level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med 1999; 16: 207-211.
26. Stenvinkel P: Endothelial dysfunction and inflammation-is there a link? Nephrol Dial Transplant 2001; 16: 1968-1971.
27. Schroeder EB, Chambless LE, Liao D, et al: Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005; 28: 668-74.
28. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH: The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 2005; 181: 101-108.